These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1860 related items for PubMed ID: 28484685

  • 1. Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi.
    Xiong K, Zhu C, Chen Z, Zheng C, Tan Y, Rao X, Cong Y.
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [Abstract] [Full Text] [Related]

  • 2. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K, Chen Z, Zhu C, Li J, Hu X, Rao X, Cong Y.
    Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
    [Abstract] [Full Text] [Related]

  • 3. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
    Zhu C, Xiong K, Chen Z, Hu X, Li J, Wang Y, Rao X, Cong Y.
    Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
    [Abstract] [Full Text] [Related]

  • 4. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH, Kantele JM, Savolainen LE, Rombo L, Kantele A.
    Vaccine; 2015 Jan 09; 33(3):451-8. PubMed ID: 25433216
    [Abstract] [Full Text] [Related]

  • 5. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.
    Wang JY, Noriega FR, Galen JE, Barry E, Levine MM.
    Infect Immun; 2000 Aug 09; 68(8):4647-52. PubMed ID: 10899868
    [Abstract] [Full Text] [Related]

  • 6. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D, Baud D, Pang SY, Schiller J, Bobst M, Zosso N, Ponci F, Nardelli-Haefliger D.
    Clin Vaccine Immunol; 2007 Oct 09; 14(10):1285-95. PubMed ID: 17687110
    [Abstract] [Full Text] [Related]

  • 7. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.
    Wahid R, Fresnay S, Levine MM, Sztein MB.
    Mucosal Immunol; 2015 Nov 09; 8(6):1349-59. PubMed ID: 25872480
    [Abstract] [Full Text] [Related]

  • 8. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH, Kantele JM, Kantele A.
    Vaccine; 2012 Sep 14; 30(42):6047-53. PubMed ID: 22858557
    [Abstract] [Full Text] [Related]

  • 9. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
    Wahid R, Simon R, Zafar SJ, Levine MM, Sztein MB.
    Clin Vaccine Immunol; 2012 Jun 14; 19(6):825-34. PubMed ID: 22492745
    [Abstract] [Full Text] [Related]

  • 10. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
    Das S, Chowdhury R, Pal A, Okamoto K, Das S.
    Immunobiology; 2019 May 14; 224(3):371-382. PubMed ID: 30952553
    [Abstract] [Full Text] [Related]

  • 11. Serodiagnosis of Salmonella enterica serovar Typhi and S. enterica serovars Paratyphi A, B and C human infections.
    Chart H, Cheasty T, de Pinna E, Siorvanes L, Wain J, Alam D, Nizami Q, Bhutta Z, Threlfall EJ.
    J Med Microbiol; 2007 Sep 14; 56(Pt 9):1161-1166. PubMed ID: 17761477
    [Abstract] [Full Text] [Related]

  • 12. Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B.
    Wahid R, Zafar SJ, McArthur MA, Pasetti MF, Levine MM, Sztein MB.
    Clin Vaccine Immunol; 2014 Mar 14; 21(3):427-34. PubMed ID: 24429069
    [Abstract] [Full Text] [Related]

  • 13. Development of a synthetic Vi polysaccharide vaccine for typhoid fever.
    Ni Y, Springer MJ, Guo J, Finger-Baker I, Wilson JP, Cobb RR, Turner D, Tizard I.
    Vaccine; 2017 Dec 18; 35(51):7121-7126. PubMed ID: 29150208
    [Abstract] [Full Text] [Related]

  • 14. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.
    Pakkanen SH, Kantele JM, Kantele A.
    Scand J Immunol; 2014 Mar 18; 79(3):222-9. PubMed ID: 24383914
    [Abstract] [Full Text] [Related]

  • 15. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
    Hart PJ, O'Shaughnessy CM, Siggins MK, Bobat S, Kingsley RA, Goulding DA, Crump JA, Reyburn H, Micoli F, Dougan G, Cunningham AF, MacLennan CA.
    PLoS One; 2016 Mar 18; 11(1):e0145945. PubMed ID: 26741681
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
    Lee HY, Cho SA, Lee IS, Park JH, Seok SH, Baek MW, Kim DJ, Lee SH, Hur SJ, Ban SJ, Lee YK, Han YK, Cho YK, Park JH.
    FEMS Immunol Med Microbiol; 2007 Nov 18; 51(2):310-8. PubMed ID: 17725620
    [Abstract] [Full Text] [Related]

  • 17. Improving Our Understanding of Salmonella enterica Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain.
    Higginson EE, Ramachandran G, Hazen TH, Kania DA, Rasko DA, Pasetti MF, Levine MM, Tennant SM.
    mSphere; 2018 Nov 28; 3(6):. PubMed ID: 30487152
    [Abstract] [Full Text] [Related]

  • 18. Vi capsular polysaccharide: Synthesis, virulence, and application.
    Hu X, Chen Z, Xiong K, Wang J, Rao X, Cong Y.
    Crit Rev Microbiol; 2017 Aug 28; 43(4):440-452. PubMed ID: 27869515
    [Abstract] [Full Text] [Related]

  • 19. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
    Kothari N, Kothari S, Choi YJ, Dey A, Briles DE, Rhee DK, Carbis R.
    Vaccine; 2015 Feb 04; 33(6):783-8. PubMed ID: 25545593
    [Abstract] [Full Text] [Related]

  • 20. Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.
    Ruan P, Xia XP, Sun D, Ojcius DM, Mao YF, Yue WY, Yan J.
    Vaccine; 2008 Dec 02; 26(51):6639-44. PubMed ID: 18834913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 93.